Alzchem Group AG (CHIX:ACTD) EPS without NRI: €6.60 (TTM As of Mar. 2026)


CHIX:ACTD Alzchem Group AG CHIX:ACTD
50 GF Score
Price €189.90
! 5 Warning Signs
View Full Analysis

What is Alzchem Group AG EPS without NRI?

Alzchem Group AG CHIX:ACTD 50 EPS without NRI is €6.60 as of Mar. 2026. GuruFocus rates CHIX:ACTD with a GF Score™ of 50/100. The stock has 5 warning signs investors should review. Among 1,261 Chemicals companies, Alzchem Group AG ranks better than 86.28% on this metric.

Alzchem Group AG's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €1.77. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €6.60.

During the past 12 months, Alzchem Group AG's average earnings per share (NRI) Growth Rate was 18.90% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 34.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 26.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Alzchem Group AG's EPS without NRI or its related term are showing as below:

CHIX:ACTd' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -70.6   Med: 4.95   Max: 34.7
Current: 34.7

During the past 13 years, Alzchem Group AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 34.70% per year. The lowest was -70.60% per year. And the median was 4.95% per year.

CHIX:ACTd's 3-Year EPS without NRI Growth Rate is ranked better than
86.28% of 1261 companies
in the Chemicals industry
Industry Median: -1.7 vs CHIX:ACTd: 34.70

Alzchem Group AG's EPS (Diluted) for the three months ended in Mar. 2026 was €1.77. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €6.61.

Alzchem Group AG's EPS (Basic) for the three months ended in Mar. 2026 was €1.77. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €6.61.


Alzchem Group AG  (CHIX:ACTd) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Alzchem Group AG EPS without NRI Related Terms


Alzchem Group AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG EPS without NRI Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 2.57 3.39 5.31 6.27

Alzchem Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.56 1.61 1.66 1.77

CHIX:ACTD vs LIN, SHW, ECL: EPS without NRI Comparison

For the Specialty Chemicals subindustry, Alzchem Group AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzchem Group AG PE Ratio without NRI vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Alzchem Group AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Alzchem Group AG's PE Ratio without NRI falls into.


CHIX:ACTD
50GF Score
Alzchem Group AG CHIX:ACTD
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €6.60 mean?
Alzchem Group AG (CHIX:ACTD) has a EPS without NRI of €6.60 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Alzchem Group AG and its competitors. According to the industry distribution chart, Alzchem Group AG ranks #173 out of 1261 companies in the Chemicals industry, placing it in the top 13.7%.
Is Alzchem Group AG's EPS without NRI too high?
Alzchem Group AG's current EPS without NRI is €6.60. Based on the distribution chart, Alzchem Group AG ranks #173 out of 1261 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Alzchem Group AG has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's EPS without NRI compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #173 out of 1261 companies for EPS without NRI. This places Alzchem Group AG in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current EPS without NRI is €6.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (CHIX:ACTD) has a current EPS without NRI of €6.60. The current EPS without NRI is €6.60. Alzchem Group AG's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Alzchem Group AG (CHIX:ACTD), the current EPS without NRI is €6.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
50GF Score

Get the complete analysis for CHIX:ACTD

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€189.90
Price